Biobank中文Project inquiry
NewsNavigation menu
R&D ServicesModels & ProductsApplicationsTechnologyEvidence & ResourcesHow We WorkAbout TRiCBIONews & EventsBiobankProject inquiry中文
← News & Events

Conferences & meetings

SITC 2026: Let's talk human tumor–immune biology

Phoenix, Arizona

Connect with TRiCBIO to discuss PDO 2.0, immunotherapy and combination studies.

MEET TRiCBIO

Human tumor–immune biology

Phoenix, Arizona
TRiCBIO · Scientific exchange

Study tumor and immune responses together

Connect with us during SITC 2026 to explore human organoids for immuno-oncology. PDO 2.0 brings source-tissue architecture and retained immune cells into the same model, supporting treatment comparisons and mechanism studies.

Start with your candidate and research question

Topics include checkpoint blockade, bispecific antibodies and combination treatments, with complementary tumor-cell, immune-cell and cytokine readouts. Bring your model-selection, study-design or collaboration questions.

Cell-death flow readouts from a PDO 2.0 study
A closer look at PDO 2.0 tumor–immune studies

Explore the science

Explore PDO 2.0 ↗View tumor–immune studies ↗Conference website ↗

Arrange a meeting

Tell us what you are working on. Our scientific team will be in touch.

Meet with our team

More from TRiCBIO